Qualitek Labs submitted its Management Discussion & Analysis for H2 FY26, reporting consolidated revenue of ₹124.52 crore, a 77% YoY increase.
H2 FY26 PAT surged 145% to ₹9.89 crore with EBITDA margin expanding to 25.7%, driven by operating leverage and integration benefits.
The company provided FY27 guidance for 35-40% revenue growth and 25-27% EBITDA margin, targeting ₹500 crore revenue by FY31.
Strategic expansion included consolidation of Interstellar Testing Centre and new labs in Mumbai and Bengaluru, bringing total to 10 owned labs.